Mincewicz G, Sopel R, Kozłowki M, Kurowski W. [Evaluation of the efficacy of nebulized salbutamol in exacerbation of chronic asthma].
Pneumonol Alergol Pol 1998;
65:788-92. [PMID:
9760793]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023] Open
Abstract
The aim of the study was to evaluate the influence of nebulized salbutamol in low doses (0.5 mg, 1 mg, 1.5 mg) on lung function in patients with acute severe asthma. The study was performed in 30 patients--22 female and 8 male. Nebulized salbutamol proved to be an effective bronchodilating drug which enables to control exacerbations in asthmatic patients receiving conventional medical treatment. The evaluation of effect of nebulized salbutamol should take into account both subjective symptoms and (basic) spirometry parameters of airway obstruction such as FEV1 PEF. This therapy can improve the efficacy of asthma management.
Collapse